Orbite Technologies Inc EORBF

RE:last I checked

[Soulinvestor]

At  .35 a share your position is not unreasonable. Orbite now has a chance to correct the failed commissioning and with their tech turn their company into a game changer. A comment was made earlier that at .35 a share, Orbite is much further ahead and more derisked than they were at $5.00. On the other hand, Orbite had engaged numerous high profile  research firms like Mackie, MPartners Jacobs Securities, Europacific etc.etc. who presented us with detailed scientific and financial reports why they believed Orbite's SP would in relatively short order climb to high single and low multible digit dollar numbers. Orbite then presented a controversial PEA by Genivar which was by and large substantiated by Roche after the AMF halted trading on the stock. Through that point, investors at least had a clear business plan with attached numbers as to where the SP was headed in the near future provided the facts on the ground coincided with what was projected by the PEA and paid analysts. Today's investor has no clear picture from the company, analysts or IMHO a reliable PEA as to what we can expect from our SP even if we successfully completed commissioning the HPA plant. The uncertainty can in part be attributed to the huge cost overruns in the HPA plant which was the basis of numerous conclusions with respect to the costs of the SGA plant that were written into the PEA along with probably a much higher than expected dillution in shares and the present management's and analysts own belief that the SGA plant would be considerably higher then the half billion estimate originally promised by Orbite. It would be helpful if management could come up with a number projection when the calcinator is ordered and all the added parts are decided on  when of course the final engineering modifications are in place.   GLTA